Kynam Capital Management, LP 13D and 13G filings for CytomX Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-05-15 4:01 pm Purchase | 2026-03-31 | 13G | CYTOMX THERAPEUTICS INC CTMX | Kynam Capital Management, LP | 15,013,093 6.900% | 6,047,016 (+67.44%) | Filing |
| 2026-03-04 3:18 pm Purchase | 2025-12-31 | 13G | CYTOMX THERAPEUTICS INC CTMX | Kynam Capital Management, LP | 8,966,077 5.290% | 8,966,077 (New Position) | Filing |